| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
| mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
| mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.0006 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.001 |
| mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |